Capital Performance Advisors »

Aquestive Therapeutics shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $593 119 4.98

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Vanguard Specialized Funds Div App Etf (VIG)
NVIDIA Corporation (NVDA)

View all positions for Capital Performance Advisors

Top funds holding Aquestive Therapeutics

Bratton Capital Management
BlackRock
Vanguard Group
VR Adviser
Franklin Resources
Geode Capital Management
MPM Oncology Impact Management
State Street Corporation
Blue Owl Capital Holdings
Janney Montgomery Scott
Goldman Sachs Group
Morgan Stanley
Bank of America Corporation
Essex Investment Management
Northern Trust

View all funds holding Aquestive Therapeutics